Paul Nguyen
Identification and integration of clinical features, genetic factors, and biomarkers to optimize prostate cancer risk stratification and treatment selection One of the most pressing dilemmas in the care of patients...Read More
David Mulholland
Evaluating the contribution of AR deficient stem/progenitor cells in Castrate Resistant Prostate Cancer The use of anti-androgens is standard treatment for prostate cancer patients in the management of PSA recurrence...Read More
Mark Pomerantz
Dr. Pomerantz earned a BS degree in American Studies from Yale University and an MD degree from Stanford University. He completed Medical Oncology Fellowship at the Dana-Farber Cancer Institute and...Read More
Heather Montie
Determining the role of the androgen receptor acetylation in prostate cancer Prostate cancer is driven by the male hormones, androgens which mediate their activity through the androgen receptor (AR). Unfortunately...Read More
Hung-Ming Lam
GPR30 as a potential therapeutic target for castration-resistant prostate cancer The protein G-protein coupled receptor 30 (GPR30) regulates several signaling pathways governing cell growth, migration etc. In previous studies, Dr....Read More
Stacey Kenfield
Lifestyle, guidelines, and etools to improve prostate cancer survivorship Under the mentorship of Dr. Chan and Dr. Stampfer, Dr. Kenfield has evaluated whether diet and lifestyle factors after prostate cancer...Read More
Kalpana Kannan
Investigating the biological significance of novel recurrent chimeric RNAs in prostate cancer Chimeric RNAs are the fused products of two different genes. Recent studies have shown that chimeric RNAs are...Read More
Matthew Galsky, MD
Dr. Matthew Galsky is currently a hematologist-oncologist at Mount Sinai Health System and a Professor of Medicine, Hematology and Medical Oncology and a Professor of Urology at the Icahn School...Read More
Sanaz Memarzadeh
Dr. Memarzadeh earned her BS in Neuroscience and her MD from the University of Pittsburgh. She has a PhD in Molecular Biology from UCLA. She did her residency in Obstetrics...Read More
Terence Friedlander
Investigation of genomic mechanisms of androgen biosynthesis inhibitor resistance in castration resistant prostate cancer In most cases the first line of therapy for patients with prostate cancer is Androgen Deprivation...Read More